| Molecular formula | C38H49N9O5 |
|---|
| Molecular weight | 711.9 g/mol |
|---|
| Registered trials | 3 |
|---|
| PubChem CID | 9831659 |
|---|
Key takeaways
- Ipamorelin has no approved drug label and is not authorized for any medical use.
- It is classified as an investigational compound, studied only in a research setting.
- Three registered clinical trials have examined ipamorelin, primarily for gastrointestinal recovery after surgery.
- Public adverse event report data for ipamorelin is not currently available.
What Ipamorelin Is
Ipamorelin is a synthetic peptide with the molecular formula C38H49N9O5 and a molecular weight of 711.9 (PubChem CID 9831659). No regulatory agency has approved a drug label for this compound, and it carries no FDA-approved indications, brand names, or established mechanism of action in official labeling. It exists only as a research and investigational substance.
Trial Footprint
Three clinical trials referencing ipamorelin are registered. Two completed studies examined its safety and efficacy compared to placebo for recovery of gastrointestinal function and for management of post-operative ileus. A third trial, listed as the Trifecta Research Study, is currently active but not recruiting. These registrations reflect research activity only and do not establish that ipamorelin is safe or effective for any use.
FAQ
No. Ipamorelin has no FDA-approved label, indications, or brand names. It is classified as an investigational compound used only in research settings.
Ipamorelin is a synthetic peptide with the molecular formula C38H49N9O5 and a molecular weight of approximately 711.9. Its chemical identity is catalogued in PubChem under CID 9831659.
Three clinical trials are registered that reference ipamorelin. Two focused on gastrointestinal recovery and post-operative ileus and have completed, while a third remains active but is not currently recruiting.
Public adverse event report data for ipamorelin is not currently available. Any safety information would come from the completed clinical trials rather than large-scale reporting databases.
Ipamorelin does not have an approved medical use and is not authorized as a treatment for any condition. It remains limited to research and clinical trial contexts.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03